The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Blood Product-Global Market Insights and Sales Trends 2025

Blood Product-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1827097

No of Pages : 120

Ask Your Query

Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The global Blood Product market size is expected to reach US$ 47570 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Product in various end use industries. The expanding demands from the Bleeding Wound, Immunodeficiency, HBV and Tetanus, are propelling Blood Product market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunoglobulin segment is estimated at % CAGR for the next seven-year period.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Blood Product market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Product market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Product sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Product covered in this report include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc.
The global Blood Product market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • Shanghai RAAS
  • China Biologic Products
  • Hualan Biological Engineering Inc.
  • Beijing Tiantan Biological Products Corp
  • Pacific Shuanglin
  • Boya Bio-Pharmaceutical
  • Paisi Feike Biology Pharmacy Co., Ltd.
  • Xinjiang Deyuan Bioengineering
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Shenzhen Weiguang
  • Shanxi Kangbao
  • Nanyue Biopharming Corporation Ltd


Global Blood Product market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)


Global Blood Product market, Segment by Type:

  • Albumin
  • Immunoglobulin
  • Clotting Factor
  • Others


Global Blood Product market, by Application

  • Bleeding Wound
  • Imunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others


Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Product companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Blood Product

1.1 Blood Product Market Overview

1.1.1 Blood Product Product Scope

1.1.2 Blood Product Market Status and Outlook

1.2 Global Blood Product Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Blood Product Market Size by Region (2018-2029)

1.4 Global Blood Product Historic Market Size by Region (2018-2023)

1.5 Global Blood Product Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Blood Product Market Size (2018-2029)

1.6.1 North America Blood Product Market Size (2018-2029)

1.6.2 Europe Blood Product Market Size (2018-2029)

1.6.3 Asia-Pacific Blood Product Market Size (2018-2029)

1.6.4 Latin America Blood Product Market Size (2018-2029)

1.6.5 Middle East & Africa Blood Product Market Size (2018-2029)

2 Blood Product Market by Type

2.1 Introduction

2.1.1 Albumin

2.1.2 Immunoglobulin

2.1.3 Clotting Factor

2.1.4 Others

2.2 Global Blood Product Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Blood Product Historic Market Size by Type (2018-2023)

2.2.2 Global Blood Product Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Blood Product Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Blood Product Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Blood Product Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Blood Product Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Blood Product Revenue Breakdown by Type (2018-2029)

3 Blood Product Market Overview by Application

3.1 Introduction

3.1.1 Bleeding Wound

3.1.2 Immunodeficiency

3.1.3 HBV

3.1.4 Tetanus

3.1.5 Rabies

3.1.6 Hemophilia

3.1.7 Others

3.2 Global Blood Product Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Blood Product Historic Market Size by Application (2018-2023)

3.2.2 Global Blood Product Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Blood Product Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Blood Product Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Blood Product Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Blood Product Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Blood Product Revenue Breakdown by Application (2018-2029)

4 Blood Product Competition Analysis by Players

4.1 Global Blood Product Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Product as of 2022)

4.3 Date of Key Players Enter into Blood Product Market

4.4 Global Top Players Blood Product Headquarters and Area Served

4.5 Key Players Blood Product Product Solution and Service

4.6 Competitive Status

4.6.1 Blood Product Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Takeda

5.1.1 Takeda Profile

5.1.2 Takeda Main Business

5.1.3 Takeda Blood Product Products, Services and Solutions

5.1.4 Takeda Blood Product Revenue (US$ Million) & (2018-2023)

5.1.5 Takeda Recent Developments

5.2 CSL

5.2.1 CSL Profile

5.2.2 CSL Main Business

5.2.3 CSL Blood Product Products, Services and Solutions

5.2.4 CSL Blood Product Revenue (US$ Million) & (2018-2023)

5.2.5 CSL Recent Developments

5.3 Grifols

5.3.1 Grifols Profile

5.3.2 Grifols Main Business

5.3.3 Grifols Blood Product Products, Services and Solutions

5.3.4 Grifols Blood Product Revenue (US$ Million) & (2018-2023)

5.3.5 Octapharma Recent Developments

5.4 Octapharma

5.4.1 Octapharma Profile

5.4.2 Octapharma Main Business

5.4.3 Octapharma Blood Product Products, Services and Solutions

5.4.4 Octapharma Blood Product Revenue (US$ Million) & (2018-2023)

5.4.5 Octapharma Recent Developments

5.5 Kedrion

5.5.1 Kedrion Profile

5.5.2 Kedrion Main Business

5.5.3 Kedrion Blood Product Products, Services and Solutions

5.5.4 Kedrion Blood Product Revenue (US$ Million) & (2018-2023)

5.5.5 Kedrion Recent Developments

5.6 LFB Group

5.6.1 LFB Group Profile

5.6.2 LFB Group Main Business

5.6.3 LFB Group Blood Product Products, Services and Solutions

5.6.4 LFB Group Blood Product Revenue (US$ Million) & (2018-2023)

5.6.5 LFB Group Recent Developments

5.7 Biotest

5.7.1 Biotest Profile

5.7.2 Biotest Main Business

5.7.3 Biotest Blood Product Products, Services and Solutions

5.7.4 Biotest Blood Product Revenue (US$ Million) & (2018-2023)

5.7.5 Biotest Recent Developments

5.8 BPL

5.8.1 BPL Profile

5.8.2 BPL Main Business

5.8.3 BPL Blood Product Products, Services and Solutions

5.8.4 BPL Blood Product Revenue (US$ Million) & (2018-2023)

5.8.5 BPL Recent Developments

5.9 Shanghai RAAS

5.9.1 Shanghai RAAS Profile

5.9.2 Shanghai RAAS Main Business

5.9.3 Shanghai RAAS Blood Product Products, Services and Solutions

5.9.4 Shanghai RAAS Blood Product Revenue (US$ Million) & (2018-2023)

5.9.5 Shanghai RAAS Recent Developments

5.10 China Biologic Products

5.10.1 China Biologic Products Profile

5.10.2 China Biologic Products Main Business

5.10.3 China Biologic Products Blood Product Products, Services and Solutions

5.10.4 China Biologic Products Blood Product Revenue (US$ Million) & (2018-2023)

5.10.5 China Biologic Products Recent Developments

5.11 Hualan Biological Engineering Inc.

5.11.1 Hualan Biological Engineering Inc. Profile

5.11.2 Hualan Biological Engineering Inc. Main Business

5.11.3 Hualan Biological Engineering Inc. Blood Product Products, Services and Solutions

5.11.4 Hualan Biological Engineering Inc. Blood Product Revenue (US$ Million) & (2018-2023)

5.11.5 Hualan Biological Engineering Inc. Recent Developments

5.12 Beijing Tiantan Biological Products Corp

5.12.1 Beijing Tiantan Biological Products Corp Profile

5.12.2 Beijing Tiantan Biological Products Corp Main Business

5.12.3 Beijing Tiantan Biological Products Corp Blood Product Products, Services and Solutions

5.12.4 Beijing Tiantan Biological Products Corp Blood Product Revenue (US$ Million) & (2018-2023)

5.12.5 Beijing Tiantan Biological Products Corp Recent Developments

5.13 Pacific Shuanglin

5.13.1 Pacific Shuanglin Profile

5.13.2 Pacific Shuanglin Main Business

5.13.3 Pacific Shuanglin Blood Product Products, Services and Solutions

5.13.4 Pacific Shuanglin Blood Product Revenue (US$ Million) & (2018-2023)

5.13.5 Pacific Shuanglin Recent Developments

5.14 Boya Bio-Pharmaceutical

5.14.1 Boya Bio-Pharmaceutical Profile

5.14.2 Boya Bio-Pharmaceutical Main Business

5.14.3 Boya Bio-Pharmaceutical Blood Product Products, Services and Solutions

5.14.4 Boya Bio-Pharmaceutical Blood Product Revenue (US$ Million) & (2018-2023)

5.14.5 Boya Bio-Pharmaceutical Recent Developments

5.15 Paisi Feike Biology Pharmacy Co., Ltd.

5.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Profile

5.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Main Business

5.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Products, Services and Solutions

5.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue (US$ Million) & (2018-2023)

5.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments

5.16 Xinjiang Deyuan Bioengineering

5.16.1 Xinjiang Deyuan Bioengineering Profile

5.16.2 Xinjiang Deyuan Bioengineering Main Business

5.16.3 Xinjiang Deyuan Bioengineering Blood Product Products, Services and Solutions

5.16.4 Xinjiang Deyuan Bioengineering Blood Product Revenue (US$ Million) & (2018-2023)

5.16.5 Xinjiang Deyuan Bioengineering Recent Developments

5.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

5.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Profile

5.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business

5.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Products, Services and Solutions

5.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue (US$ Million) & (2018-2023)

5.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments

5.18 Shenzhen Weiguang

5.18.1 Shenzhen Weiguang Profile

5.18.2 Shenzhen Weiguang Main Business

5.18.3 Shenzhen Weiguang Blood Product Products, Services and Solutions

5.18.4 Shenzhen Weiguang Blood Product Revenue (US$ Million) & (2018-2023)

5.18.5 Shenzhen Weiguang Recent Developments

5.19 Shanxi Kangbao

5.19.1 Shanxi Kangbao Profile

5.19.2 Shanxi Kangbao Main Business

5.19.3 Shanxi Kangbao Blood Product Products, Services and Solutions

5.19.4 Shanxi Kangbao Blood Product Revenue (US$ Million) & (2018-2023)

5.19.5 Shanxi Kangbao Recent Developments

5.20 Nanyue Biopharming Corporation Ltd

5.20.1 Nanyue Biopharming Corporation Ltd Profile

5.20.2 Nanyue Biopharming Corporation Ltd Main Business

5.20.3 Nanyue Biopharming Corporation Ltd Blood Product Products, Services and Solutions

5.20.4 Nanyue Biopharming Corporation Ltd Blood Product Revenue (US$ Million) & (2018-2023)

5.20.5 Nanyue Biopharming Corporation Ltd Recent Developments

6 North America

6.1 North America Blood Product Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Blood Product Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Blood Product Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Blood Product Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Blood Product Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Blood Product Market Dynamics

11.1 Blood Product Industry Trends

11.2 Blood Product Market Drivers

11.3 Blood Product Market Challenges

11.4 Blood Product Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock